RBC Europe’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $43K | Hold |
202
| – | – | ﹤0.01% | 340 |
|
|
2022
Q1 | $57K | Sell |
202
-18
| -8% | -$5.08K | ﹤0.01% | 332 |
|
|
2021
Q4 | $83K | Hold |
220
| – | – | ﹤0.01% | 301 |
|
|
2021
Q3 | $90.8K | Hold |
220
| – | – | ﹤0.01% | 438 |
|
|
2021
Q2 | $81.4K | Hold |
220
| – | – | ﹤0.01% | 474 |
|
|
2021
Q1 | $63.8K | Hold |
220
| – | – | ﹤0.01% | 501 |
|
|
2020
Q4 | $55K | Hold |
220
| – | – | ﹤0.01% | 496 |
|
|
2020
Q3 | $49.8K | Hold |
220
| – | – | ﹤0.01% | 459 |
|
|
2020
Q2 | $38.4K | Hold |
220
| – | – | ﹤0.01% | 498 |
|
|
2020
Q1 | $27.8K | Hold |
220
| – | – | ﹤0.01% | 489 |
|
|
2019
Q4 | $33.6K | Hold |
220
| – | – | ﹤0.01% | 544 |
|
|
2019
Q3 | $29.1K | Hold |
220
| – | – | ﹤0.01% | 551 |
|
|
2019
Q2 | $31.2K | Hold |
220
| – | – | ﹤0.01% | 561 |
|
|
2019
Q1 | $32K | Hold |
220
| – | – | ﹤0.01% | 558 |
|
|
2018
Q4 | $24.9K | Hold |
220
| – | – | ﹤0.01% | 588 |
|
|
2018
Q3 | $29.6K | Hold |
220
| – | – | ﹤0.01% | 595 |
|
|
2018
Q2 | $24.7K | Hold |
220
| – | – | ﹤0.01% | 629 |
|
|
2018
Q1 | $23.5K | Hold |
220
| – | – | ﹤0.01% | 643 |
|
|
2017
Q4 | $24.1K | Hold |
220
| – | – | ﹤0.01% | 634 |
|
|
2017
Q3 | $23.8K | Buy |
+220
| New | +$23.8K | ﹤0.01% | 647 |
|